Sign inGet started

Renz Justin A

Insider CIK 1466562 · ZLCS SVP, CFO & Treasurer · ZVRA CFO · ARDX Chief Financial Officer · KPTI EVP, CFO & Treasurer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZVRA ZEVRA THERAPEUTICS, INC. A Award deriv2026-03-182026-03-19300,000— $0300,000SEC↗
ARDX ARDELYX, INC. S Sale2025-08-212025-08-257,037$5.93 $41.7K409,052SEC↗
ARDX ARDELYX, INC. S Sale2025-05-202025-05-227,218$4.08 $29.4K416,089SEC↗
ARDX ARDELYX, INC. A Award deriv2025-02-252025-02-27205,019— $0205,019SEC↗
ARDX ARDELYX, INC. A Award2025-02-252025-02-27136,680— $0422,648SEC↗
ARDX ARDELYX, INC. S Sale2025-02-202025-02-215,171$5.62 $29.1K285,968SEC↗
ARDX ARDELYX, INC. S Sale2024-11-202024-11-225,260$4.79 $25.2K291,139SEC↗
ARDX ARDELYX, INC. S Sale2024-08-202024-08-225,289$5.86 $31.0K295,257SEC↗
ARDX ARDELYX, INC. S Sale2024-05-212024-05-235,167$7.81 $40.4K300,546SEC↗
ARDX ARDELYX, INC. S Sale2024-02-202024-02-225,341$8.75 $46.7K304,835SEC↗
ARDX ARDELYX, INC. A Award deriv2024-01-162024-01-18164,000— $0164,000SEC↗
ARDX ARDELYX, INC. A Award2024-01-162024-01-18127,750— $0310,176SEC↗
ARDX ARDELYX, INC. M Exercise deriv2023-12-262023-12-2875,000— $0121,000SEC↗
ARDX ARDELYX, INC. S Sale2023-12-262023-12-28225,000$6.36 $1.43M182,426SEC↗
ARDX ARDELYX, INC. M Exercise2023-12-262023-12-2875,000$0.99 $74.3K407,426SEC↗
ARDX ARDELYX, INC. S Sale2023-11-202023-11-222,873$4.36 $12.5K332,426SEC↗
ARDX ARDELYX, INC. S Sale2023-08-212023-08-232,884$3.55 $10.2K333,849SEC↗
ARDX ARDELYX, INC. S Sale2023-05-232023-05-252,873$3.65 $10.5K336,733SEC↗
ARDX ARDELYX, INC. S Sale2023-02-212023-02-243,439$3.00 $10.3K336,606SEC↗
ARDX ARDELYX, INC. A Award deriv2023-01-052023-01-06351,000— $0351,000SEC↗
ARDX ARDELYX, INC. A Award2023-01-052023-01-0678,000— $0340,045SEC↗
ARDX ARDELYX, INC. S Sale2022-11-222022-11-231,443$1.95 $2.8K262,045SEC↗
ARDX ARDELYX, INC. S Sale2022-11-222022-11-2361$1.94 $118263,488SEC↗
ARDX ARDELYX, INC. P Buy2022-08-312022-09-013,000$0.62 $1.9K263,549SEC↗
ARDX ARDELYX, INC. S Sale2022-08-222022-08-2412$0.98 $12260,549SEC↗
ARDX ARDELYX, INC. S Sale2022-08-222022-08-246$0.98 $6260,561SEC↗
ARDX ARDELYX, INC. S Sale2022-08-222022-08-241,480$0.98 $1.5K260,567SEC↗
ARDX ARDELYX, INC. S Sale2022-06-062022-06-0871,794$0.65 $46.7K263,565SEC↗
ARDX ARDELYX, INC. S Sale2022-06-062022-06-081,518$0.64 $972262,047SEC↗
ARDX ARDELYX, INC. S Sale2022-05-202022-05-231,528$0.67 $1.0K335,359SEC↗
ARDX ARDELYX, INC. S Sale2022-02-222022-02-251,800$0.67 $1.2K333,887SEC↗
ARDX ARDELYX, INC. A Award deriv2022-01-062022-01-12196,000— $0196,000SEC↗
ARDX ARDELYX, INC. A Award2022-01-062022-01-1242,000— $0335,687SEC↗
ARDX ARDELYX, INC. S Sale2021-11-222021-11-24643$0.99 $637293,687SEC↗
ARDX ARDELYX, INC. A Award2021-10-082021-10-29250,000— $0294,330SEC↗
ARDX ARDELYX, INC. S Sale2021-08-202021-08-24631$1.32 $83340,047SEC↗
ARDX ARDELYX, INC. S Sale2021-05-202021-05-21612$7.09 $4.3K40,678SEC↗
ARDX ARDELYX, INC. S Sale2021-02-222021-02-24608$6.88 $4.2K41,290SEC↗
ARDX ARDELYX, INC. A Award deriv2021-01-052021-01-07146,755— $0146,755SEC↗
ARDX ARDELYX, INC. A Award2021-01-052021-01-0732,612— $041,898SEC↗
ARDX ARDELYX, INC. S Sale2020-09-152020-09-173,714$5.49 $20.4K9,286SEC↗
ARDX ARDELYX, INC. A Award deriv2020-06-082020-06-09195,017— $0195,017SEC↗
ARDX ARDELYX, INC. A Award2020-06-082020-06-0910,000— $013,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2017-01-202017-01-24100,000— $0100,000SEC↗
KPTI Karyopharm Therapeutics In S Sale2016-11-092016-11-144,342$8.19 $35.6K19,173SEC↗
KPTI Karyopharm Therapeutics In M Exercise deriv2016-11-052016-11-0815,000— $015,000SEC↗
KPTI Karyopharm Therapeutics In M Exercise2016-11-052016-11-0815,000— $023,515SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2016-01-152016-01-20100,000— $0100,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2015-11-052015-11-0930,000— $030,000SEC↗
KPTI Karyopharm Therapeutics In P Buy2015-04-022015-04-065,000$29.71 $148.6K5,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2015-01-192015-01-2245,000— $045,000SEC↗
KPTI Karyopharm Therapeutics In A Award deriv2014-09-112014-09-15245,000— $0245,000SEC↗
ZLCS Zalicus Inc. A Award2014-02-102014-02-12250,000— $0250,000SEC↗
ZLCS Zalicus Inc. A Award deriv2013-01-032013-01-07280,000— $0280,000SEC↗
ZLCS Zalicus Inc. A Award deriv2012-01-252012-01-27313,121— $0313,121SEC↗
ZLCS Zalicus Inc. A Award deriv2012-01-252012-01-27111,879— $0111,879SEC↗